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Dear Editor,
The historic British referendum on June 23, 2016 has perhaps 
placed in the hands of our European Union (EU) a couple 
of stunning cards to play in order to improve our position 
in the international arena. The Brexit decision was very 
controversial as the percentage of people that voted for Brexit 
was not much higher than those that voted to remain in the 
EU (51.9% voted to leave whilst 48.1% voted to remain). 
In addition, there were great differences between different 
territories (eg, 62% of Scotland voted to remain) and age 
ranges (eg, 73% of 18-24 year-olds and 62% among 25-34s 
voted to remain).1 A recent debate on the impact of Brexit on 
research was held on May 8, 2017 at the Royal Institution in 
London, and organised in collaboration with EuroScience and 
the European Academy. The debate clearly demonstrated on 
one hand the lack of preparedness of the science community, 
as a whole, to face the challenges ahead and, on the other, the 
fear of the loss of influence of UK researchers on the European 
scene was palpable during the discussions.2 Several comments 
immediately following the British vote for Brexit focused on 
the negative effects both in general terms and in individual 
sectors, such as that of scientific research.3,4 Immigration, is 
the issue on which those seeking Brexit have focused most. 
‘Freedom of Movement’ is a core principle of the EU, enshrined 
in its treaties, alongside the other three basic freedoms of 
movement of goods, capital and services and is a concrete 
manifestation of EU citizenship.5 Many benefits to UK public 
health from EU legislation would likely be retained after a 
Brexit. The health service faces severe financial constraints 
and appears to lurch from crisis to crisis, with leaving the EU 
likely to exacerbate many problems including staffing issues 
across the whole sector. However, new scientific developments 
and digital technology offer societies everywhere massive 
and unprecedented opportunities for improving health. It is 
vital for the country that the National Health Service (NHS) 
is able to adopt these discoveries and see them translated 
into improved patient care and population health, but also 
that the United Kingdom benefits from its capabilities and 
strengths in these areas.6 It would have to pay to participate 
in EU structures. Post-Brexit UK might be able to participate 
in research, as do Switzerland, Norway, and Israel, among 
others, by buying into the programme but it would have no 
input to policy. Moreover, its participation would depend on 
what the EU would allow.7 The EU budget for 2014–2020 for 
research, development, and innovation is estimated at €120 
billion, including €74.8 billion in the current Framework 
Programmes, known as Horizon 2020.8 UK health research 
received €119.9 million in 2015 from Horizon 2020 programs, 
equal to 22.2%, 20.7% and 20.2% of the EU-13, EU-15 and 
EU-28, respectively3; whether or not they can continue to 
participate in such funding programs after Brexit will need to 
be renegotiated. 
How scientific development will be distributed in the next years 
depends on the knowledge, skill, motivation and organization 
of research teams, but other factors are equally important. 
How research funding is distributed among disciplines, areas, 
countries or teams is of key importance in the evolution of the 
scientific landscape. In the last years, EU funding for research 
has been uneven. Even so, some countries were still able to 
contribute to research while receiving insufficient funding, 
despite being less advanced in innovation and research.4
At least two factors that are not related to scientific value 
can influence the distribution of research funding, thus 
contributing to deepen the gap among more and less 
scientifically developed countries and disciplines of science 
(countries with non-scientific advantage would attract more 
funding, which in turn would increase their scientific value 
compared to countries or disciplines attracting less funding, 
which finally would increase the scientific advantage to further 
attract funding). The first of these factors is language. English 
speaking countries (or countries with a large penetration 
of English as a second language, such as the Nordic and 
Scandinavian area) have shown to receive more funding than 
predominantly non-English speaking countries. Though 
their superior performance could be partially a consequence 
of overall scientific superiority, the difference in researchers’ 
ability to write in good English cannot be overlooked as a 
source of financing inequality.
From a linguistic point of view, although English is the first 
language in the scientific world, this is not so for many EU 
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citizens. If we want science to have an impact that is evenly 
dispersed among the European population, the unfair language 
bias must be removed. The official language for countries 
applying for funding applications should be considered, 
especially in projects with social impact in countries where the 
population does not speak English, as this involves a double 
effort. First, applying in English and later in translating all the 
material or content for the language of every country, with all 
its social and cultural implications. If the United Kingdom is 
no longer able to access EU funding, their portion of the pie 
becomes available for other countries in Europe to use in their 
own research. Countries such as Italy and Spain with strong 
research initiatives and infrastructure and great research 
potential could take advantage of the newly available funding 
more so than countries such as Germany, the Netherlands, 
and France that already receive ample amounts of funding. 
In this scenario, removing a strong competitor with natural 
language advantage could potentially allow other countries 
to emerge. The second non-scientific factor influencing 
the ability to attract research funding is priority. Financing 
agencies establish European funding priorities based on 
consensus. The process to consensus includes the opinion of 
administrators, politicians, and citizens; also scientists and 
research institutions are requested to provide feedback on 
their perception of priority, but the exact mechanisms how 
consensus is obtained is not clearly defined. Our prediction is 
that the distribution of scientific research funding developed 
under the EU-27 will be altered and that possibly we will see 
major impacts from Italy and Spain (or other countries now 
accounting for small allocations of funds). It is also likely that 
countries with large allocations of research funds (Germany, 
France, the Netherlands) will increase their participation.
The idea that any country can act entirely independently 
in a globalized world, or should do, is a dangerous 
fantasy. Understanding challenges and opportunities that 
rehabilitation researchers may face once the United Kingdom 
leaves the EU will help to prepare rehabilitation researchers in 
the EU for the next decade.3,4
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